Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease
暂无分享,去创建一个
R. Idilman | Ç. Uzun | B. Savaş | E. Peker | A. Erden | S. Turhan | C. Tulunay | Nil Özyüncü | Z. Ellik | Beliz Bahar Karaoğlan | Diğdem Kuru
[1] Sanjiv J. Shah,et al. Longitudinal Association of Non‐Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study , 2020, Journal of the American Heart Association.
[2] El-Sayed H. Ibrahim,et al. Practical Guide to Evaluating Myocardial Disease by Cardiac MRI. , 2020, AJR. American journal of roentgenology.
[3] A. Khera,et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.
[4] N. Chalasani,et al. Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[5] J. Canada,et al. Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance. , 2019, The American journal of cardiology.
[6] Byung Gyu Kim,et al. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study. , 2017, Journal of hepatology.
[7] E. Kang,et al. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. , 2017, Journal of hepatology.
[8] V. Alla,et al. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. , 2017, Diabetes & metabolic syndrome.
[9] A. Greiser,et al. Assessment of Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance T1 Mapping: Correlation with Left-Ventricular Diastolic Dysfunction and Diabetic Duration , 2017, Journal of diabetes research.
[10] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[11] Yingying Ding,et al. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis , 2016, Scientific Reports.
[12] Corrado Barbui,et al. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. , 2016, Journal of hepatology.
[13] Eike Nagel,et al. T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review. , 2016, Circulation research.
[14] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[15] L. Adams,et al. International Journal of Molecular Sciences the Natural Course of Non-alcoholic Fatty Liver Disease , 2022 .
[16] A. Lonardo,et al. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease , 2016, Digestive Diseases and Sciences.
[17] Sanjiv J. Shah,et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population‐based study , 2015, Hepatology.
[18] E. Bonora,et al. Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes , 2015, PloS one.
[19] E. Kang,et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). , 2015, Journal of hepatology.
[20] C. Byrne,et al. NAFLD: a multisystem disease. , 2015, Journal of hepatology.
[21] G. Marchesini,et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. , 2015, Journal of hepatology.
[22] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.
[23] Yong-Jin Kim,et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. , 2015, Radiology.
[24] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[25] C. Catalano,et al. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease , 2014, Hepatology.
[26] S. Day,et al. The ubiquitin proteasome system in human cardiomyopathies and heart failure. , 2013, American journal of physiology. Heart and circulatory physiology.
[27] Andrew S Flett,et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.
[28] James D. Thomas,et al. Mortality rate in patients with diastolic dysfunction and normal systolic function. , 2011, Archives of internal medicine.
[29] P. Scifo,et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver , 2007, Hepatology.
[30] S. Goland,et al. Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment , 2006, Journal of clinical gastroenterology.
[31] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[32] Daniel S Berman,et al. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. , 2004, Journal of the American College of Cardiology.
[33] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[34] Shah Ebrahim,et al. JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .
[35] S. Johnson. Data collection and IT. , 2001, Professional nurse.
[36] Hasan Karabulut,et al. Koroner Arter Hastalarında Miyokard Performans İndeksinin Sol Ventrikül Fonksiyonlarını Değerlendirmede Önemi , 2000 .
[37] D. Rader,et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. , 1999, Mayo Clinic proceedings.
[38] J. Seward,et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. , 1995, Journal of cardiology.